Clinical trials of riluzole in patients with ALS

被引：64

作者：

Miller, RG

Bouchard, JP

Duquette, P

Eisen, A

Gelinas, DF

Harati, Y

Munsat, TL

Powe, L

Rothstein, J

Salzman, P

Sufit, RL

Guillet, P

Bensimon, G

Delumeau, JC

Durrleman, S

Lacomblez, L

Leigh, PN

Meininger, V

Maloteaux, JM

Delwaide, C

Girard, M

Masse, C

Blin, O

Azulay, JP

Billeturc, F

Pouget, J

Bouche, P

Camu, W

Carlander, B

Clanet, M

Angibaud, G

ArneBes, MC

Benazet, M

Couratier, P

Desnuelle, C

Lagueny, A

Ellie, E

Dib, M

Rozier, A

Salachas, F

Viader, F

Delaunay, D

Dengler, R

Guther, G

Troger, M

Ludolph, A

Bachus, R

Gericke, C

Przuntek, H

Langkafel, M

机构：

[1] HOP ENFANTS JESUS, DEPT NEUROL SCI, QUEBEC CITY, PQ, CANADA

[2] NOTRE DAME HOSP, DEPT NEUROL, MONTREAL, PQ, CANADA

[3] VANCOUVER HOSP & HLTH SCI CTR, NEUROMUSCULAR DIS UNIT, VANCOUVER, BC V5Z 1M9, CANADA

[4] BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA

[5] TUFTS UNIV NEW ENGLAND MED CTR, DEPT NEUROL, BOSTON, MA 02111 USA

[6] RHONE POULENC RORER, ANTONY, FRANCE

[7] RHONE POULENC RORER, COLLEGEVILLE, PA USA

[8] NORTHWESTERN UNIV, SCH MED, DEPT NEUROL, CHICAGO, IL 60611 USA

[9] JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA

[10] HOP LA PITIE SALPETRIERE, DEPT PHARMACOL, PARIS, FRANCE

[11] INST PSYCHIAT, DEPT NEUROL, LONDON SE5 8AF, ENGLAND

[12] UNIV LOUVAIN, BRUSSELS, BELGIUM

[13] HOP ENFANTS LA TIMONE, MARSEILLE, FRANCE

[14] HOP G CHAULIAC, MONTPELLIER, FRANCE

[15] HOP PURPAN, TOULOUSE, FRANCE

[16] HOP LOUIS PASTEUR, F-06002 NICE, FRANCE

[17] HOP HAUT LEVEQUE, PESSAC, FRANCE

[18] HOP DUPUYTEN, LIMOGES, FRANCE

[19] CHU COTE NACRE, CAEN, FRANCE

[20] HANNOVER MED SCH, HANNOVER, GERMANY

[21] UNIV BERLIN, NEUROL KLIN, BERLIN, GERMANY

[22] INST SALUD CARLOS III, MADRID, SPAIN

[23] QUEENS MED CTR, NOTTINGHAM NG7 2UH, ENGLAND

[24] CHARING CROSS HOSP, LONDON, ENGLAND

[25] ROYAL PRESTON HOSP, PRESTON, LANCS, ENGLAND

[26] QUEEN ELIZABETH HOSP, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND

[27] MANCHESTER ROYAL INFIRM, MANCHESTER M13 9WL, LANCS, ENGLAND

[28] QUEEN VICTORIA INFIRM, NEWCASTLE UPON TYNE, TYNE & WEAR, ENGLAND

[29] ROYAL LONDON HOSP, LONDON E1 1BB, ENGLAND

[30] BAYLOR COLL MED, HOUSTON, TX USA

[31] VAMC, HOUSTON, TX USA

[32] CALIF PACIFIC MED CTR, SAN FRANCISCO, CA USA

来源：

NEUROLOGY | 1996年 / 47卷 / 04期

关键词：

D O I：

10.1212/WNL.47.4_Suppl_2.86S

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Two double-blinded, placebo-controlled clinical trials of riluzole have now been carried out in more than 1,100 patients with ALS. The results of both studies show a modest benefit in prolonging survival that is statistically significant. These results led to the availability of this drug by the Food and Drug Administration for use in the United States beginning in early 1996. This is the first drug that has been available for ALS. It begins a new era in both basic and clinical research in an attempt to find a cure for this disease.

引用

页码：S86 / S90

页数：5

共 50 条

[1] Clinical trials of riluzole in patients with ALS - Discussion
Gutmann, L
Miller, RG
Neville, H
Strong, M
Salzman, P
Rowland, LP
Mitsumoto, H
[J]. NEUROLOGY, 1996, 47 (04) : S90 - S92
[2] Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS
Favero, Francis Meire
Voos, Mariana Callil
de Castro, Isac
Caromano, Fatima Aparecida
Bulle Oliveira, Acary Souza
[J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2017, 75 (08) : 515 - 522
[3] Evidence for a multimodal effect of riluzole in patients with ALS?
de Jongh, Adriaan D.
van Eijk, Ruben P. A.
van den Berg, Leonard H.
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (10): : 1183 - +
[4] ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population?
Chio, Adriano
Mora, Gabriele
Moglia, Cristina
Fuda, Giuseppe
Canosa, Antonio
Gallo, Sara
Cammarosano, Stefania
Ilardi, Antonio
Calvo, Andrea
[J]. NEUROLOGY, 2011, 76 (09) : A367 - A368
[5] Clinical Trial Testing Lithium Carbonate and Riluzole in Patients with ALS Terminates Early for Futility
Aggarwal, Swati P.
Zinman, Lorne
Schoenfeld, David
Conwit, Robin
Shefner, Jeremy
Cudkowicz, Merit
[J]. NEUROLOGY, 2010, 74 (09) : A283 - A283
[6] ALS clinical trials Do enrolled patients accurately represent the ALS population?
Chio, A.
Canosa, A.
Gallo, S.
Cammarosano, S.
Moglia, C.
Fuda, G.
Calvo, A.
Mora, G.
[J]. NEUROLOGY, 2011, 77 (15) : 1432 - 1437
[7] Riluzole treatment in advanced ALS
Borasio, GD
[J]. JOURNAL OF NEUROLOGY, 2002, 249 (05) : 505 - 506
[8] Clinical Trials for Neuroprotection in ALS
Siciliano, G.
Carlesi, C.
Pasquali, L.
Piazza, S.
Pietracupa, S.
Fornai, F.
Ruggieri, S.
Murri, L.
[J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (03) : 305 - 313
[9] Advances in ALS clinical trials
Mitsumoto, H
[J]. AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 374 - 384
[10] Biomarkers and clinical trials in ALS
Genge, Angela
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455

← 1 2 3 4 5 →